HiFiBiO

BiotechnologySeries DCambridge, UShifibio.com

Latest round

Series D

Last raised

Jun 2021

Total raised

$180M

Investors

17

About HiFiBiO

Founded in 2013 and based in Cambridge, US, HiFiBiO Inc. is an emerging clinical stage multinational company that engages the use of human immune system to treat cancer and autoimmune disease. The company's main business include development of immunomodulatory antibody products and single cell scientific research. It uses immunosuppressive cell types, suppression and stimulation pathways, and multi-effect immunomodulators to change the immune balance of cancer and autoimmune diseases. In addition, the company conducts single-cell research through solutions such as immune cell analysis, functional screening, and sequence-based deep phenotypic characterization, and applies droplet based microfluidic technology in conjunction with other single-cell approaches to drug discovery and drug development. The company will advance two lead antibody oncology assets into Phase I clinical trials – HFB200301, a novel anti-TNFR2 antibody and HFB301001, a differentiated second generation anti-OX-40 antibody.

Who invested in HiFiBiO

17 investors across 4 rounds

See all investors in HiFiBiO

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Jun 14, 2021

    Amount

    $75M

    Investors

    Locked

  2. Series C

    Aug 28, 2019

    Amount

    $67M

    Investors

    Locked

  3. Series B

    May 16, 2018

    Amount

    $38M

    Investors

    Locked

  4. Series A

    Sep 1, 2016

    Amount

    Undisclosed

    Investors

    Locked

Questions about HiFiBiO

Who invested in HiFiBiO?

HiFiBiO has 17 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has HiFiBiO raised?

HiFiBiO has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did HiFiBiO last raise money?

HiFiBiO's most recent round on record is a Series D, in Jun 2021.

What does HiFiBiO do?

Founded in 2013 and based in Cambridge, US, HiFiBiO Inc.

Where is HiFiBiO headquartered?

HiFiBiO is headquartered in Cambridge, US.

Which VCs invest in companies like HiFiBiO?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at HiFiBiO's stage. Their profiles are linked below.

Raising like HiFiBiO? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.